相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Self-assembling, supramolecular chemistry and pharmacology of amphotericin B: Poly-aggregates, oligomers and monomers
Raquel Fernandez-Garcia et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Improved In Vitro Anti-Mucorales Activity and Cytotoxicity of Amphotericin B with a Pegylated Surfactant
Kevin Brunet et al.
JOURNAL OF FUNGI (2022)
Intestinal Absorption Study: Challenges and Absorption Enhancement Strategies in Improving Oral Drug Delivery
Maisarah Azman et al.
PHARMACEUTICALS (2022)
The drug resistance mechanisms in Leishmania donovani are independent of immunosuppression
Baibaswata Saha et al.
CYTOKINE (2021)
Unveiling the Amphotericin B Degradation Pathway and Its Kinetics in Lipid-Based Solutions
Everton N. Alencar et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Current approaches in lipid-based nanocarriers for oral drug delivery
Maria Plaza-Oliver et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2021)
Delivery strategies of amphotericin B for invasive fungal infections
Xiaochun Wang et al.
ACTA PHARMACEUTICA SINICA B (2021)
Amphotericin B-loaded Eudragit RL100 nanoparticles coated with hyaluronic acid for the treatment of vulvovaginal candidiasis
Carolina Mirtes Melo et al.
CARBOHYDRATE POLYMERS (2020)
Pharmacokinetics and tissue distribution of an orally administered mucoadhesive chitosan-coated amphotericin B-Loaded nanostructured lipid carrier (NLC) in rats
Janet Sui Ling Tan et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2020)
Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
Celia Faustino et al.
PHARMACEUTICS (2020)
Safety, Tolerability, and Pharmacokinetics of a Novel Oral Amphotericin B Formulation (iCo-019) following Single-Dose Administration to Healthy Human Subjects: an Alternative Approach to Parenteral Amphotericin B Administration
Peter Hnik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Strategies to enhance oral delivery of amphotericin B: a comparison of uncoated and enteric-coated nanostructured lipid carriers
Pataranapa Nimtrakul et al.
DRUG DELIVERY (2020)
The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?
Grace Cuddihy et al.
PHARMACEUTICS (2019)
Improved Oral Bioavailability and Gastrointestinal Stability of Amphotericin B through Fatty Acid Conjugation Approach
Kaushik Thanki et al.
MOLECULAR PHARMACEUTICS (2019)
Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo Approaches
David Dahlgren et al.
PHARMACEUTICS (2019)
Intestinal permeability enhancement of benzopyran HP1-loaded nanoemulsions
Gabriela C. Meirelles et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Intestinal permeability determinants of norfloxacin in Ussing chamber model
Cassiana Mendes et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity
D. M. Casa et al.
EXPERIMENTAL PARASITOLOGY (2018)
In-vitro and in-vivo antileishmanial activity of inexpensive Amphotericin B formulations: Heated Amphotericin B and Amphotericin B-loaded microemulsion
Andreza Rochelle do Vale Morais et al.
EXPERIMENTAL PARASITOLOGY (2018)
Mechanism of Binding of Antifungal Antibiotic Amphotericin B to Lipid Membranes: An Insight from Combined Single-Membrane Imaging, Microspectroscopy, and Molecular Dynamics
Ewa Grela et al.
MOLECULAR PHARMACEUTICS (2018)
Regional Intestinal Permeability in Rats: A Comparison of Methods
Carl Roos et al.
MOLECULAR PHARMACEUTICS (2017)
Excised segments of rat small intestine in Ussing chamber studies: A comparison of native and stripped tissue viability and permeability to drugs
Erik Sjogren et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Stearylamine-Containing Cationic Nanoemulsion as a Promising Carrier for Gene Delivery
Andre L. Silva et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2016)
Development and Characterization of a Microemulsion System Containing Amphotericin B with Potential Ocular Applications
Walteca Louis Lima da Silveira et al.
CURRENT DRUG DELIVERY (2016)
Oral Particle Uptake and Organ Targeting Drives the Activity of Amphotericin B Nanoparticles
Dolores R. Serrano et al.
MOLECULAR PHARMACEUTICS (2015)
Does P-glycoprotein contribute to amphotericin B epithelial transport in Caco-2 cells?
Jo-Ann Osei-Twum et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2015)
Influence of the Freeze-Drying Process on the Physicochemical and Biological Properties of Pre-heated Amphotericin B Micellar Systems
Scheyla D. V. S. Siqueira et al.
AAPS PHARMSCITECH (2014)
In Vitro and In Vivo Evidence for Amphotericin B as a P-Glycoprotein Substrate on the Blood-Brain Barrier
Ji-Qin Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
ABC transporters coupled with the elevated ergosterol contents contribute to the azole resistance and amphotericin B susceptibility
Biao Ren et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2014)
Self-Association of Amphotericin B: Spontaneous Formation of Molecular Structures Responsible for the Toxic Side Effects of the Antibiotic
Joanna Starzyk et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2014)
Human in Vivo Regional Intestinal Permeability: Importance for Pharmaceutical Drug Development
Hans Lennernas
MOLECULAR PHARMACEUTICS (2014)
Amphotericin forms an extramembranous and fungicidal sterol sponge
Thomas M. Anderson et al.
NATURE CHEMICAL BIOLOGY (2014)
Development of oil-in-water microemulsions for the oral delivery of amphotericin B
Acarilia Eduardo Silva et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Excipients with specialized functions for effective drug delivery
Josias Hamman et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Sensitive, Accurate and Simple Liquid Chromatography-Tandem Mass Spectrometric Method for the Quantitation of Amphotericin B in Human or Minipig Plasma
WeiGe Qin et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2012)
Physical and chemical stability of drug nanoparticles
Libo Wu et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
A guide to Ussing chamber studies of mouse intestine
Lane L. Clarke
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Lipid Nano Spheres (LNSs) for enhanced oral Bioavailability of amphotericin B: Development and characterization
Basant Amarji et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2007)
Innovative methods to study human intestinal drug metabolism in vitro:: Precision-cut slices compared with Ussing chamber preparations
Esther G. van de Kerkhof et al.
DRUG METABOLISM AND DISPOSITION (2006)
Potential mechanisms by which Peceol (R) increases the gastrointestinal absorption of Amphotericin B
V Risovic et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2004)
The solubility ceiling: A rationale for continuous infusion amphotericin B therapy?
RE Lewis et al.
CLINICAL INFECTIOUS DISEASES (2003)
Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry
C Polson et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Use of amphotericin B as optical probe to study conformational changes and thermodynamic stability in human serum albumin
D Romanini et al.
JOURNAL OF PROTEIN CHEMISTRY (2002)
Amphotericin B/emulsion admixture interactions:: An approach concerning the reduction of amphotericin B toxicity
EST Egito et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
The effect of serum albumin on amphotericin B aggregate structure and activity
SC Hartsel et al.
PHARMACEUTICAL RESEARCH (2001)
分享论文
